T:

Niels W C J van de Donk1, Philippe Moreau2, Jesús F San-Miguel3

  • 1Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands.

PubMed
概括

新型T细胞免疫疗法,包括嵌合抗原受体 (CAR) T细胞和双特异性抗体,为多发性髓瘤提供了新的希望. 建议首先对符合条件的患者进行CAR T细胞治疗,优先考虑安全性和有效性.